DR JILL RICHARDSON, Executive Director, Head of Biology, MSD UK
Jill has an outstanding track record of contribution to neuroscience research and drug discovery within the Pharmaceutical Industry having spent 23 years at GlaxoSmithKline before joining MSD in 2018, where she leads a highly talented group of scientists with a breadth of leading molecular/cell biology skill sets, based at the London Bioscience Innovation Centre (LBIC). She has collaborated extensively with academic groups and has contributed to delivery of scientific findings that have challenged previous concepts. With over 130 peer-reviewed publications, she is internationally recognised for her broad expertise in neuroscience research and drug discovery and has made important contributions to neurological diseases including Alzheimer’s disease, multiple sclerosis, pain and epilepsy during her career in the pharmaceutical industry.
She obtained both her degree in biochemistry and PhD in Developmental Biology from the University of Warwick before taking up a Fogarty Post-Doctoral Award at the National Institutes of Health, Bethesda, U.S.
She is a Fellow of the Royal Society of Biology and has a Visiting Professorship at Imperial College London. She serves on several national and international Advisory Boards including the Wellcome Trust, MRC DRI Quinquennial panel and ARUK DDI Review Panel.